One candidate inward-facing PCR primer pair, written to , isThe forward PCR primer binds the intronic flank immediately upstream of exon 5; the reverse PCR primer is the reverse complement of a downstream exon-5 segment. Their amplicon includes the repeat while both binding sites lie outside it. Using the displayed reference sequence gives an approximately -base-pair product; an indel changes the intervening length and sequence. The primers have matched simple Wallace-rule estimates near . These are candidates from the supplied sequence: confirm genomic specificity, absence of variable primer-binding sites, secondary structures and actual reaction conditions before use. Sequence from a unique flank toward the repeat and verify a single specific product.
Two desirable properties are similar primer melting temperatures, allowing one annealing condition to support both primers efficiently, and specific binding with little self-complementarity or mutual complementarity, especially at the ends, to reduce off-target products and primer dimers. Suitable length and a balanced GC content help achieve these goals. A long homopolymer, strong hairpin or repeated genomic binding site would compromise a candidate even if its calculated melting temperature looked acceptable.
The repetitive tract can cause DNA polymerase slippage during PCR amplification or the sequencing extension itself, generating stutter products. A heterozygous length variant creates overlapping Sanger sequencing traces downstream of the indel because the two templates lose register; this does not by itself indicate random sequencing failure. Tumor heterogeneity or contamination by normal tissue can add further mixed templates. Avoid creating or obscuring the mutation during amplification and avoid interpreting a mixed trace as one clean allele. Use a suitable high-fidelity DNA polymerase, independent amplifications and bidirectional reads, and resolve individual alleles by molecular cloning or an appropriate single-molecule/amplicon sequencing method if necessary. Check for non-specific products and allelic dropout caused by variation in a primer-binding site.
A practical design uses one common exon-4 forward PCR primer with an exon-specific reverse PCR primer for each transcript isoform. Candidate sequences, all written to , areUse for TCF-long and for TCF-short: recognizes exon 5, while recognizes exon 6. The displayed mature reference sequences predict approximately - and -base-pair products, respectively. Check actual splice products because a transcript with unexpected exon combinations could defeat the assumed specificity. The simple melting-temperature estimates are approximately , and .
Prepare matched RNA, remove contaminating DNA, carry out reverse transcription and validate each RT-qPCR assay with known isoform standards, a single-product check, a no-template control and a no-reverse-transcriptase control. The primers span an intron in the genomic arrangement but do not themselves cross a splice junction, so the DNA control remains important. Calibrate amplification efficiency and fluorescence response before comparing molecule numbers between the two assays. A redesigned junction-specific assay is another option once additional suitable flanking sequence is available.
Use RNA sequencing and quantify reads spanning the exon-4/exon-5 and exon-4/exon-6 splice junctions, with appropriate normalization for informative read opportunities. These distinguish production of the long- and short-associated transcript isoforms rather than merely measuring total TCF transcription factor transcripts. Adequate junction coverage and biological replication are required; long-read RNA sequencing can independently check whether the assumed complete isoforms are present. This avoids relying on a comparison of raw Ct values from two different PCR primer pairs.
Using the stated curve assignments, read approximately and for Caco-2, and and for differentiated Caco-2. If both assays double product per cycle and have comparable threshold calibration,Therefore TCF-short:TCF-long is approximately in Caco-2 and after differentiation. The short:long ratio rises about sixteenfold; under the supplied legend, this pilot result does not support preferential expression of TCF-long after differentiation. These are approximate graph-based estimates, particularly because fractional-cycle readings can noticeably change a large ratio. Cross-assay molecule ratios require validated efficiencies and calibration standards; equal-looking plateaus do not establish either assumption.
A housekeeping Ct is unnecessary for the within-sample short:long ratio, because a common reference cancels. With matched doubling efficiencies,However, a validated reference such as TATA-binding protein transcript is needed when comparing the abundance of either isoform separately between samples while correcting for input, RNA recovery and reverse transcription. Reference stability must be tested under the differentiation conditions. Neither reference normalization nor cancellation removes the need to validate the two isoform assays' efficiencies and response calibration.
The ascending-colon tumors carry the exon-5 frameshift mutation in sampled patients, transverse tumors in , and descending and sigmoid tumors in each. Grouping these gives proximal tumors versus distal tumors with the repeat alteration, suggesting proximal enrichment of this molecular subtype. The matched samples show a one-allele alteration in the adjacent tissue of patients 1 and 7, whereas patients 5 and 9 have tumor-associated alterations without a detected alteration in their matched normal sample.
This is a small case series, and all ten patients already have tumors. It cannot determine whether a region has a higher absolute risk of transformation, nor establish defective DNA mismatch repair from one altered repeat alone. Larger location-matched series, population denominators, testing of additional microsatellites and direct assessment of DNA mismatch repair components are needed to support those stronger claims.
The lower region can contain both the genuine TCF-short product and a truncated product derived from the exon-5-containing TCF-long transcript. A repeat frameshift mutation creates an early stop codon, producing a long-derived product close in size to TCF-short. The N-terminal antibody recognizes their shared retained region. The two nearby bands need not represent two copies of the normal short splice product. In patient 1's healthy sample, one mutated allele permits a truncated product alongside intact long and short products; in the tumor, mutation of both alleles explains loss of the intact long band while short-sized products remain. Test the assignment with an exon-5/C-terminal-specific reagent or peptide identification; phosphorylation or other modifications could also create doublets, so mobility alone is not definitive.
Prepare nuclear extract from the specified pancreatic cell line, retaining DNA-binding activity and protecting against degradation. Make and label a double-stranded DNA probe containing the two candidate binding sites and their flanks. Incubate equal probe amounts with extract under suitable binding conditions, including non-specific competitor DNA. Prepare the extract-only binding reaction and separate reactions containing anti-TCF transcription factor or anti-HNF1β antibody; keep other conditions and input amounts matched. Resolve the reactions by non-denaturing polyacrylamide gel electrophoresis and detect the labelled probe. Binding changes probe mobility; addition of an appropriate antibody can produce a supershift. Include probe integrity and a probe-only reference, and avoid denaturing reagents that destroy the complexes being measured.
It is the free labelled DNA probe, not bound in the slower-moving protein–DNA complexes. Its smaller effective hydrodynamic size allows faster migration. Excess unbound probe commonly gives a strong lower band; a probe-only lane would verify this assignment and distinguish it from a labelled degradation product.
A strong specificity control is competition with a large excess of unlabelled cognate promoter DNA. It should reduce the shifted labelled complexes, whereas an unrelated or binding-site-mutant competitor should compete much less effectively. This tests sequence-dependent association rather than non-specific probe retention. A probe-only lane identifies the free probe, and an irrelevant isotype-matched antibody controls whether any added antibody produces aggregation or altered mobility. These controls address different uncertainties and should not be treated as interchangeable.
The extract forms a slower-migrating labelled complex. Addition of either anti-TCF transcription factor or anti-HNF1β replaces much of the lower shifted band with an even slower species. The results support participation of both TCF transcription factor and HNF1β in promoter-associated complexes, assuming the antibodies are specific. The separate supershifts are consistent with their presence together, but cannot exclude two unresolved, similarly migrating complexes containing one factor each. They do not by themselves establish direct binding of each factor to its own predicted motif, physical interaction between the factors, or occupation of the native promoter in intact biological cells. Mutant binding sites, purified components and a chromatin-occupancy assay address those distinct claims.
Include both specific antibodies in the same electrophoretic mobility shift assay and compare with each single-antibody reaction and isotype controls. An additional double supershift of one defined complex would support simultaneous occupancy, especially when reproduced with purified TCF transcription factor, HNF1β and one probe containing the paired sites. Mutating each site separately tests the relevant binding requirement. Failure to obtain a double supershift is not decisive because antibody binding may be sterically incompatible or disruptive. For the native promoter, sequential chromatin immunoprecipitation with the two factors, with reciprocal order and background controls, can test co-association with the same promoter-containing chromatin fragment; it does not alone prove direct contact or base-specific binding.
Co-transfect a reference reporter gene expressed from a suitable constitutive promoter, such as a Renilla luciferase construct, alongside the experimental firefly luciferase reporter. Normalize experimental luminescence to the reference signal to reduce variation in transfection, cell number and recovery. The reference promoter must be insensitive to the tested Wnt signalling and HNF1β manipulations; otherwise the denominator introduces an apparent effect. Keep total transfected DNA comparable and confirm that the assay signals are within their measurable range.
The empty expression plasmid controls for introducing the vector and transfection reagents without adding either TCF transcription factor isoform. It establishes reporter activity supported by endogenous factors and, when used to balance DNA amounts, controls total plasmid load between conditions. Changes relative to this baseline can then be attributed more specifically to the expressed transgene. It is not a substitute for an independent normalization reporter or for checking that the two transgenes produce comparable amounts of functional protein.
There is no large, consistent stimulation by added Wnt protein ligand in the displayed experiment. The paired bars are close in the empty-vector and TCF-long conditions; TCF-short shows a modest upward difference, while some other pairs decrease slightly. The error bars and absence of raw replicate information do not permit a firm significance claim. This result concerns the particular reporter and transfection conditions, not every aspect of endogenous Wnt signalling. A known ligand-responsive positive control, dose/time testing and validation of receptor/pathway competence would distinguish a genuinely weak response from failed stimulation or saturation caused by transgene expression.
Without added HNF1β, both TCF transcription factor isoforms increase reporter output over the empty-vector baseline, with TCF-short giving the larger increase. Adding HNF1β leaves TCF-short output near – arbitrary units, but reduces TCF-long-associated output from roughly to –, approximately a tenfold reduction. The empty-vector baseline falls only modestly. HNF1β therefore supports strong isoform-selective repression associated with TCF-long, while TCF-short remains activating in this assay.
This pattern is consistent with recruitment of a transcription corepressor through the long-specific interaction motif. To test that mechanism directly, mutate the motif while preserving expression and DNA binding, rescue with the intact version, mutate the promoter binding sites, and measure the abundance and localization of both factors. Reporter output alone does not establish the molecular contact or the same quantitative effect at the endogenous GLP-1 receptor locus. The question prose and figure caption name different host cell lines, so cell-line-specific mechanistic conclusions require clarification of that source inconsistency.
Replacing the acceptor's A with C changes the canonical splice site from AG to CG. The predicted primary effect is impaired recognition of the exon-5 acceptor, reducing normal exon-5 inclusion. If the processing machinery instead selects exon 6, TCF-long would decrease and TCF-short would increase, removing the long-specific corepressor-interaction sequence from more of the translated products. Other outcomes are possible, including a cryptic acceptor, intron retention, unstable transcripts or altered total expression; the nucleotide change does not uniquely determine one mature product. Test allele-specific RNA splicing by junction assays and sequencing, with matched alleles or an edited endogenous locus. Unlike a repeat indel, this is initially a splice-site perturbation rather than necessarily a coding-region frameshift mutation.
An increased colorectal-cancer risk is mechanistically plausible in the supplied model, but not demonstrated by these data. Reduced normal TCF-long production and a shift toward TCF-short could weaken a differentiated-cell expression program and favor proliferation. This resembles one functional consequence of truncating long products, but the splice-site allele and repeat frameshift mutations are distinct changes, and the allele need not itself impair DNA mismatch repair. The pancreatic HNF1β reporter result cannot establish the mechanism in colon epithelium, where the relevant cofactors and targets differ.
Determine actual allele-specific isoforms and total protein in colon tissue, test proliferation and differentiation in matched edited cells or organoids, and compare allele frequencies in well-controlled case and population samples. The table of repeat mutations supplies no direct association test for this SNP. The designation as a diabetes-risk allele alone does not establish either the direction or size of a colorectal-cancer association.
Articles by others on the same topic
There are currently no matching articles.